Thyroid and Thyroid Cancer Clinic
The UCSF Pediatric Thyroid and Thyroid Cancer Clinic diagnoses and cares for children with thyroid conditions such as thyroid cancer, thyroid nodules and autoimmune thyroid disease, including Graves’ and Hashimoto’s diseases. As part of the endocrinology and metabolism division, our clinic also screens for thyroid cancer and thyroid disease in patients with inherited tumor predisposition syndromes such as multiple endocrine neoplasia (MEN) syndromes.
Our clinic combines the knowledge and skills of experts in the field along with resources such as imaging, biopsy and genetic testing to tailor treatment for your child. We work closely with other specialists at UCSF, including those in endocrine and general surgery; ear, nose and throat (ENT) care; pediatric oncology; medical genetics; and pathology to provide patients with comprehensive care.
Our locations (2)
Our team
-
Jessica Gosnell
MD
Endocrine Surgery, General Surgery -
Tina Hu
MD
Pediatric Endocrinology -
Lia Jacobson
MD
Pediatric Otolaryngology -
Maya Lodish
MD, MS
Pediatric Endocrinology -
Kimberly Luu
MD
Pediatric Otolaryngology -
Arun Rangaswami
MD
Pediatric Hematology-Oncology -
Sanziana A. Roman
MD
Endocrine Surgery -
Julie Ann Sosa
MD, MA
Endocrine Surgery -
Lan Vu
MD
General Surgery, Pediatric Surgery -
Natalie Wu
MD, MS
Pediatric Hematology-Oncology
Awards & recognition
-
Ranked among the nation's best in 11 specialties
-
Best in Northern California and top 10 in the nation for cancer care
-
One of the nation's best for endocrinology & diabetes care
-
Designated an early phase clinical trials core site by the Children's Oncology Group
Plan your visit
What to Bring
- Photo I.D.
- Health insurance card
- Insurance authorization, if required
- Doctor's referral, if required
- Recent test results related to your child's condition
- List of medications, including dosages, plus any your child is allergic to
- List of questions you may have
- Device or paper for taking notes
Clinical trials
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Determine the overall, pulmonary, structural, and biochemical response rate to selpercatinib in patients with RET fusion differentiated thyroid cancer treated with 6 months of selpercatinib prior to 131I therapy
Recruiting
More about this study
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarco...
Estimated four year thoracic event free survival (tEFS) where tEFS is calculated as the time from study enrollment to thoracic cavity event. Any recurrence within the pulmonary parenchyma, involving the pleural surface or the drai...
Recruiting
More about this study
Project: Every Child for Younger Patients With Cancer
The number of patients who agree to be in the Biobanking part of the study and have leftover tumor tissue and some normal blood, bone marrow, or other tissue saved for future research.
Recruiting
More about this study
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Adva...
Will be estimated over time and considered in relationship to changes in treatment trial cohort status (activations, suspensions, terminations).
Recruiting
More about this study
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusi...
The Kaplan-Meier method will be used to estimate 3-year FFS along with 80% log-minus-log transformed confidence limits for very low risk (VLR) patients.
Recruiting
More about this study
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Child...
EFS time is calculated from time of randomization to Arms A or B to first episode of disease relapse or progression, second malignancy, or death, or until last contact if no event has occurred.
Recruiting
More about this study
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma...
Response rates at the end of Cycle 2 will be calculated as the percent of evaluable patients who are responders, and confidence intervals will be constructed using the Wilson score interval method. Any eligible type II/III patient...
Recruiting
More about this study
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinom...
Safety of ET140203 T cells as assessed by the number of adverse events (AEs) after infusion
Recruiting
More about this study
Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
irRECIST criteria
Recruiting
More about this study
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
The primary endpoint is the complete pulmonary structural response rate to larotrectinib by modified Nies et al thyroid cancer response criteria.
Recruiting
More about this studyFetal surgery firsts
The first open fetal surgery in the world was performed at UCSF in the early 1980s.
